+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trial Management System Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

  • ID: 4852090
  • Report
  • April 2018
  • Region: Global
  • 241 pages
  • Transparency Market Research
1 of 2

Global Clinical Trial Management System Market: Overview

A clinical trial management system (CTMS) is a software solution targeted at the life sciences industry. Clinical trial management solution is primarily employed to manage a large amount of data involved in a clinical trial including planning, preparation, and performance and reporting. The system emphasizes keeping up-to-date contact information of participants and tracking deadlines for interim reports and regulatory approvals. In some cases, CTMS may also provide data to a business intelligence system, which acts as a digital dashboard for trial managers. It provides a user-friendly infrastructure that enables clinicians to manage trials of varying complexity. However, lack of awareness, longer approval time of clinical trials, and strict regulations to enroll patients for clinical trials restrict the expansion of the market.

The global clinical trial management system report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on mode of delivery, component, type, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global clinical trial management system market.

Global Clinical Trial Management System Market: Key Segments

Based on mode of delivery the global clinical trials management system market can be segmented into on-premise, web-based, and cloud-based. In terms of component, the global clinical trials management system market can be classified into software, hardware, and services. In addition, the global clinical trials management system market has been classified into enterprise-based, site-based clinical trial management system. Furthermore, the global clinical trial management system has been categorized into pharmaceutical industries, contract research organizations and healthcare providers. The global clinical trial management system market has been analyzed based on number of clinical trials performed, technology trend, expenditure on emergent technology, and presence of key players in the region. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Clinical Trial Management System Market: Regional Outlook

In terms of geography, the global clinical trials management system market can be categorized into North America (the U.S., Canada), Europe (the U.K., Germany, France, Russia, Poland, and Rest of Europe), Asia (China, India, South Korea, Taiwan, and Rest of Asia), and Rest of the World. The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the clinical trials management system are Oracle, Medidata, and Parexel International Corporation (now part of Pamplona Capital Management LLC),  International Business Machines Corporation, Cinven, MedNet Solutions, Inc., Microsoft, Apple Inc., Wipro Limited, Bio-Optronics Inc., Cognizant Technology Solutions Corporations, DSG, Inc., Forte Research Systems, Inc., Veeva Systems, DATATRAK Int, and others.

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1.Report Scope and Market Segmentation
1.2.Research Highlights
1.3.Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary : Global Clinical Trial Management System Market

4. Market Overview
4.1. Introduction
4.1.1. Clinical Trial Management System Definition
4.1.2. Key Industry Evolutions/ Developments
4.2. Overview: Global Clinical Trial Management System (CTSM) Market
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Porter’s Five Force Analysis
4.6. Product Pipeline
4.7. Standards for data management in clinical trial study

5. Global Clinical Trial Management System (CTMS) Market Analysis, by Mode of Delivery
5.1. Introduction & Definition
5.2. Key Findings
5.3. Market Value Forecast, by Mode of Delivery , 2015-2025
5.3.1. On-premise
5.3.2. Web-based
5.3.3. Cloud-based
5.4. Market Attractiveness, by Mode of Delivery

6. Global Clinical Trial Management System (CTMS) Market Analysis, by Component
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast, by Component, 2015-2025
6.3.1. Software
6.3.2. Hardware
6.3.3. Services
6.4. Market Attractiveness, by Components

7. Global Clinical Trial Management System (CTMS) Market Analysis, by Type
7.1. Introduction & Definition
7.2. Key Findings
7.3. Market Value Forecast, by Type, 2015-2025
7.3.1. Enterprise-based
7.3.2. Site-based
7.4. Market Attractiveness, by Type

8. Global Clinical Trial Management System (CTMS) Market Analysis, by End-user
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast, by End-user, 2015-2025
8.3.1. Pharmaceutical Industries
8.3.2. Contract Research Organizations
8.3.3. Healthcare Providers
8.4. Market Attractiveness, by End-user

9. Global Clinical Trial Management System (CTMS) Market Analysis, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia
9.2.4. Rest of the World
9.3. Market Attractiveness by Region

10. North America Clinical Trial Management System Analysis and Forecast
10.1. Key Findings
10.2. North America Clinical Trial Management System (CTMS) Market Overview
10.3. Market Value Share, by Country/Sub-regions
10.3.1. U.S.
10.3.2. Canada
10.4. Market Value Share, by Mode of Delivery
10.4.1. Cloud-bases
10.4.2. Web-based
10.4.3. On-premise
10.5. Market Value Share, by Component
10.5.1. Software
10.5.2. Hardware
10.5.3. Services
10.6. Market Value Share, by Type
10.6.1. Enterprise-based
10.6.2. Site-based
10.7. Market Value Share, by End-user
10.7.1. Pharmaceutical Industries
10.7.2. Contract Research Organizations
10.7.3. Healthcare Providers
10.8. Market Attractiveness Analysis
10.8.1. By Country/Sub-region
10.8.2. By Mode of Delivery
10.8.3. By Component
10.8.4. By Type
10.8.5. By End-user

11. Europe Clinical Trial Management System Analysis and Forecast
11.1. Key Findings
11.2. Europe Clinical Trial Management System (CTMS) Market Overview
11.3. Market Value Share, by Country/Sub-regions
11.3.1. U.K.
11.3.2. France
11.3.3. Germany
11.3.4. Russia
11.3.5. Poland
11.3.6. Rest of Europe
11.4. Market Value Share, by Mode of Delivery
11.4.1. Cloud-based
11.4.2. Web-based
11.4.3. On-premise
11.5. Market Value Share, by Component
11.5.1. Software
11.5.2. Hardware
11.5.3. Services
11.6. Market Value Share, by Type
11.6.1. Enterprise-based
11.6.2. Site-based
11.7. Market Value Share, by End-user
11.7.1. Pharmaceutical Industries
11.7.2. Contract Research Organizations
11.7.3. Healthcare Providers
11.8. Market Attractiveness Analysis
11.8.1. By Country/Sub-region
11.8.2. By Mode of Delivery
11.8.3. By Component
11.8.4. By Type
11.8.5. By End-user

12. Asia Clinical Trial Management System Analysis and Forecast
12.1. Key Findings
12.2. Asia Clinical Trial Management System (CTMS) Market Overview
12.3. Market Value Share, by Country/Sub-regions
12.3.1. China
12.3.2. South Korea
12.3.3. Taiwan
12.3.4. India
12.3.5. Rest of Asia
12.4. Market Value Share, by Mode of Delivery
12.4.1. Cloud-based
12.4.2. Web-based
12.4.3. On-premise
12.5. Market Value Share, by Component
12.5.1. Software
12.5.2. Hardware
12.5.3. Services
12.6. Market Value Share By Type
12.6.1. Enterprise-based
12.6.2. Site-based
12.7. Market Value Share By End-user
12.7.1. Pharmaceutical Industries
12.7.2. Contract Research Organizations
12.7.3. Healthcare Providers
12.8. Market Attractiveness Analysis
12.8.1. By Country/Sub-region
12.8.2. By Mode of Delivery
12.8.3. By Component
12.8.4. By Type
12.8.5. By End-user

13. Rest of World (ROW) Clinical Trial Management System Market Analysis and Forecast
13.1. Key Findings
13.2. ROW Clinical Trial Management System (CTMS) Market Overview
13.3. Market Value Share By Mode of Delivery
13.3.1. Cloud-based
13.3.2. Web-based
13.3.3. On-premise
13.4. Market Value Share By Component
13.4.1. Software
13.4.2. Hardware
13.4.3. Services
13.5. Market Value Share By Type
13.5.1. Enterprise-based
13.5.2. Site-based
13.6. Market Value Share By End-user
13.6.1. Pharmaceutical Industries
13.6.2. Contract Research Organizations
13.6.3. Healthcare Providers
13.7. Market Attractiveness Analysis
13.7.1. By Mode of Delivery
13.7.2. By Component
13.7.3. By Type
13.7.4. By End-user

14. Competition Landscape
14.1.Market Player - Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis By Company (2016)
14.3.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
14.3.1. Oracle
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Medidata
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. PAREXEL International Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. International Business Machines Corporation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Cinven
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. MedNet Solutions, Inc
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Microsoft
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Apple Inc
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Bio-Optronics, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Cognizant Technology Solutions Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. DSG, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Forte Research Systems, Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Veeva Systems
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Financial Overview
14.3.13.3. Product Portfolio
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. DATATRAK Int
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Financial Overview
14.3.14.3. Product Portfolio
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll